172 related articles for article (PubMed ID: 25574741)
21. Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR.
Reid AL; Freeman JB; Millward M; Ziman M; Gray ES
Clin Biochem; 2015 Oct; 48(15):999-1002. PubMed ID: 25523300
[TBL] [Abstract][Full Text] [Related]
22. Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.
Jönsson G; Dahl C; Staaf J; Sandberg T; Bendahl PO; Ringnér M; Guldberg P; Borg A
Oncogene; 2007 Jul; 26(32):4738-48. PubMed ID: 17260012
[TBL] [Abstract][Full Text] [Related]
23. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
[TBL] [Abstract][Full Text] [Related]
24. Next-Generation Sequencing Reveals Pathway Activations and New Routes to Targeted Therapies in Cutaneous Metastatic Melanoma.
Carlson JA; Caldeira Xavier JC; Tarasen A; Sheehan CE; Otto G; Miller VA; Stephens PJ; Elvin JA; Vergilio JA; Suh J; Gay LM; Ross JS
Am J Dermatopathol; 2017 Jan; 39(1):1-13. PubMed ID: 28045747
[TBL] [Abstract][Full Text] [Related]
25. Molecular markers detecting circulating melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevance.
Nezos A; Lembessis P; Sourla A; Pissimissis N; Gogas H; Koutsilieris M
Clin Chem Lab Med; 2009; 47(1):1-11. PubMed ID: 19055471
[TBL] [Abstract][Full Text] [Related]
26. Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression.
Pinzani P; Mazzini C; Salvianti F; Massi D; Grifoni R; Paoletti C; Ucci F; Molinara E; Orlando C; Pazzagli M; Neri B
Melanoma Res; 2010 Aug; 20(4):303-10. PubMed ID: 20442676
[TBL] [Abstract][Full Text] [Related]
27. Detection of circulating tumor cells by photoacoustic flowmetry.
Weight RM; Viator JA
Methods Mol Biol; 2014; 1102():655-63. PubMed ID: 24259004
[TBL] [Abstract][Full Text] [Related]
28. S100-EPISPOT: A New Tool to Detect Viable Circulating Melanoma Cells.
Cayrefourcq L; De Roeck A; Garcia C; Stoebner PE; Fichel F; Garima F; Perriard F; Daures JP; Meunier L; Alix-Panabières C
Cells; 2019 Jul; 8(7):. PubMed ID: 31330795
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma.
de Lange MJ; van Pelt SI; Versluis M; Jordanova ES; Kroes WG; Ruivenkamp C; van der Burg SH; Luyten GP; van Hall T; Jager MJ; van der Velden PA
Oncotarget; 2015 Nov; 6(35):37824-35. PubMed ID: 26462151
[TBL] [Abstract][Full Text] [Related]
30. Detection of melanoma cells displaying multiple genomic changes in histopathologically negative sentinel lymph nodes.
Ulmer A; Fischer JR; Schanz S; Sotlar K; Breuninger H; Dietz K; Fierlbeck G; Klein CA
Clin Cancer Res; 2005 Aug; 11(15):5425-32. PubMed ID: 16061857
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of immunocytochemistry for the detection of the BRAF(V600E) mutation in circulating tumor cells from metastatic melanoma patients.
Hofman V; Ilie M; Long-Mira E; Giacchero D; Butori C; Dadone B; Selva E; Tanga V; Passeron T; Poissonnet G; Emile JF; Lacour JP; Bahadoran P; Hofman P
J Invest Dermatol; 2013 May; 133(5):1378-81. PubMed ID: 23303445
[No Abstract] [Full Text] [Related]
32. Application of a filtration- and isolation-by-size technique for the detection of circulating tumor cells in cutaneous melanoma.
De Giorgi V; Pinzani P; Salvianti F; Panelos J; Paglierani M; Janowska A; Grazzini M; Wechsler J; Orlando C; Santucci M; Lotti T; Pazzagli M; Massi D
J Invest Dermatol; 2010 Oct; 130(10):2440-7. PubMed ID: 20535130
[TBL] [Abstract][Full Text] [Related]
33. Chondroitin sulfate proteoglycan-4 does not protect melanoma cells during inhibition of PI3K and mTOR pathways.
Javaid S; Terai K; Dudek AZ
Anticancer Res; 2015 Mar; 35(3):1279-84. PubMed ID: 25750275
[TBL] [Abstract][Full Text] [Related]
34. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
[TBL] [Abstract][Full Text] [Related]
35. A Novel Strategy for Detection and Enumeration of Circulating Rare Cell Populations in Metastatic Cancer Patients Using Automated Microfluidic Filtration and Multiplex Immunoassay.
Magbanua MJ; Pugia M; Lee JS; Jabon M; Wang V; Gubens M; Marfurt K; Pence J; Sidhu H; Uzgiris A; Rugo HS; Park JW
PLoS One; 2015; 10(10):e0141166. PubMed ID: 26496203
[TBL] [Abstract][Full Text] [Related]
36. Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.
Harbst K; Staaf J; Måsbäck A; Olsson H; Ingvar C; Vallon-Christersson J; Ringnér M; Borg A; Jönsson G
Melanoma Res; 2010 Oct; 20(5):381-91. PubMed ID: 20848731
[TBL] [Abstract][Full Text] [Related]
37. Detection of circulating malignant cells by RT-PCR in long-term clinically disease-free I stage melanoma patients.
Baldi A; Dragonetti E; Battista T; Groeger AM; Esposito V; Baldi G; Santini D
Anticancer Res; 2000; 20(5C):3923-8. PubMed ID: 11268478
[TBL] [Abstract][Full Text] [Related]
38. Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas.
Griewank KG; Westekemper H; Murali R; Mach M; Schilling B; Wiesner T; Schimming T; Livingstone E; Sucker A; Grabellus F; Metz C; Süsskind D; Hillen U; Speicher MR; Woodman SE; Steuhl KP; Schadendorf D
Clin Cancer Res; 2013 Jun; 19(12):3143-52. PubMed ID: 23633454
[TBL] [Abstract][Full Text] [Related]
39. Immunomagnetic detection of micrometastatic cells in bone marrow in uveal melanoma patients.
Eide N; Faye RS; Høifødt HK; Øvergaard R; Jebsen P; Kvalheim G; Fodstad Ø
Acta Ophthalmol; 2009 Nov; 87(8):830-6. PubMed ID: 19055657
[TBL] [Abstract][Full Text] [Related]
40. Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients.
Koyanagi K; O'Day SJ; Gonzalez R; Lewis K; Robinson WA; Amatruda TT; Kuo C; Wang HJ; Milford R; Morton DL; Hoon DS
Clin Cancer Res; 2006 Feb; 12(4):1137-43. PubMed ID: 16489066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
